Welcome to our dedicated page for Nutanix SEC filings (Ticker: NTNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nutanix filings document material events for a cloud software company with Class A common stock and a subscription-based operating model. Recent 8-K disclosures cover operating and financial results, share repurchase authorizations, accelerated share repurchase activity, and a completed private placement of Class A common stock.
Governance filings address amended bylaws, stockholder meeting results, equity incentive plan changes, executive compensation arrangements and related capital-structure matters. These records also disclose material agreements, board actions and procedural changes affecting stockholder nominations, meeting authority, indemnification and equity compensation.
NTNX: Form 144 notice reporting an insider sale of 18,653 shares. The filing lists a sale by Tarkan Maner of 18,653 common shares on 05/29/2026 for $974,488.68. The report also lists previously issued restricted stock grants dated 09/15/2022 (10,074 shares) and 03/15/2023 (20,532 shares) as securities described in the filing.
Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Rule 144 notice to sell 18,653 shares of Common stock of the issuer trading under NTNX on NASDAQ on 05/29/2026.
The filing lists the specific securities and grant dates: 4,785 Restricted Stock (06/15/2024), 3,559 Performance Shares (09/15/2024), 4,505 Restricted Stock (12/15/2024) and 5,804 Restricted Stock (03/15/2025).
Nutanix reported solid quarterly growth in its latest 10-Q, with revenue for the three months ended April 30, 2026 rising to $703.1M from $639.0M a year earlier. Net income for the quarter increased to $72.1M, and nine‑month net income reached $237.2M on revenue of $2.10B. Gross profit expanded as total cost of revenue remained modest relative to sales, while operating expenses grew but at a slower pace than revenue, supporting higher income from operations. The company generated strong operating cash flow of $601.7M over nine months, maintained a sizable cash and investments balance of $2.02B, and managed its capital structure with low‑coupon convertible notes and an undrawn $500M revolver. Nutanix also continued significant share repurchases, and after quarter end issued $150M of Class A shares to Advanced Micro Devices, Inc. in a private placement.
Nutanix reported strong third-quarter fiscal 2026 results, with revenue of $703.1 million, up 10% year over year, and Annual Recurring Revenue of $2.43 billion, up 15%. GAAP operating income was $70.5 million, while non-GAAP operating income reached $156.5 million with a 22.3% operating margin.
GAAP net income was $72.1 million, or $0.25 per diluted share. Free cash flow for the quarter was $197.2 million, slightly below the prior year, but nine‑month free cash flow improved to $563.1 million. Management stated results exceeded the high end of all guided metrics and raised full‑year 2026 guidance to $2.82–$2.84 billion in revenue, approximately 22.5% non‑GAAP operating margin, and $760–$780 million in free cash flow.
The company highlighted new AI and cloud offerings, plus a strategic alliance with NetApp, and announced a $750 million increase to its share repurchase authorization, signaling ongoing capital return alongside growth and profitability.
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC reported beneficial ownership of 15,155,213 shares of Nutanix, Inc. Class A common stock. The filing states this position represents 5.71% of the class as reported and includes convertible notes representing 699 shares.
The filing shows shared voting power of 14,740,803 shares and shared dispositive power of 15,155,213 shares. The Schedule 13G is signed by an authorized signatory on 05/15/2026 and names AQR Capital Management, LLC as a wholly owned subsidiary of AQR Capital Management Holdings, LLC.
Nutanix, Inc. disclosed that it completed a private sale of equity to raise new cash. On May 4, 2026, the company issued and sold 4,136,789 shares of its Class A common stock to Advanced Micro Devices, Inc. (AMD) at $36.26 per share, for an aggregate cash purchase price of approximately $150 million.
The transaction was completed under a Stock Purchase Agreement dated February 23, 2026 and was structured as a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933.
Nutanix Inc disclosed that Vanguard Capital Management beneficially owned 14,131,782 shares of Common Stock, representing 5.32% of the class. The filing states Vanguard has sole dispositive power over 14,131,782 shares and sole voting power over 2,051,457 shares.
The statement explains the holding reflects securities managed across Vanguard business divisions and funds; the signer is Ashley Grim, dated 04/30/2026.
Nutanix Inc ownership disclosure: Vanguard Portfolio Management reports beneficial ownership of 14,066,977 shares of Nutanix common stock, representing 5.3% of the class as of 03/31/2026. The filing states Vanguard has sole power to dispose of 14,066,977 shares and sole voting power for 57,752 shares. The Schedule 13G identifies Vanguard Portfolio Management and affiliated voting/dispositive arrangements and is signed on 04/29/2026.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix, Inc. announced that its Board of Directors has authorized an additional $750 million for its existing common stock repurchase program, bringing total authorization to approximately $779 million, including about $29 million that remained under the prior approval.
The company states that this decision reflects confidence in its long‑term strategy and financial strength, noting that its balance sheet allows it to keep investing in innovation and growth while also returning capital to shareholders in a disciplined way. Nutanix may repurchase shares over time through open market purchases, privately negotiated deals or Rule 10b5‑1 trading plans, with no minimum amount required and no expiration date on the authorization.
Nutanix ownership disclosure: The Vanguard Group filed an Amendment No. 10 to its Schedule 13G/A reporting 0 shares beneficially owned of Nutanix common stock, equal to 0%. The filing explains an internal realignment effective January 12, 2026 that led certain Vanguard subsidiaries and business divisions to report separately. The amendment is signed by Ashley Grim on March 27, 2026.